Sign in

CIK 0001401914

  • Non-accelerated filer
  • Smaller reporting company

Dare Bioscience, Inc.

Sign in to watch
Ticker
DARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
204139823
Phone
+1 858-926-7655
Business address
3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
Former names
Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Principal Accounting Officer acquired 1,098 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 2,291 shares at an average $2.08 ($4,763)
  7. 4 Open-market buy Director bought 8,960 shares at an average $2.10 ($18,842)
  8. 4 Open-market buy Director bought 8,811 shares at an average $2.00 ($17,645)
  9. 4 Open-market buy Director bought 8,850 shares at an average $2.05 ($18,172)
  10. 4 Open-market buy Director bought 9,000 shares at an average $2.15 ($19,318)
  11. 4 Open-market buy Director bought 8,563 shares at an average $2.30 ($19,706)
  12. 4 Open-market buy Director bought 8,413 shares at an average $2.32 ($19,540)
  13. 4 Open-market buy Director bought 5,700 shares at an average $2.38 ($13,550)
  14. 4 Open-market buy Director bought 9,000 shares at an average $2.46 ($22,132)
  15. 4 Open-market buy Director bought 8,800 shares at an average $2.39 ($21,075)
  16. 4 Open-market buy Director bought 9,000 shares at an average $2.28 ($20,523)
  17. 4 Open-market buy Director bought 8,900 shares at an average $2.43 ($21,660)
  18. 4 Open-market buy Director bought 8,572 shares at an average $2.53 ($21,711)
  19. 4 Open-market buy Director bought 8,684 shares at an average $2.79 ($24,209)
  20. 4 Open-market buy Director bought 8,855 shares at an average $2.87 ($25,408)

Page 8 of 12 · 240 filings